The clinical profile of a non-selected population treated with sacubitril/valsartan is different from PARADIGM-HF trial

26 May 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Heart failure prognosis and the options to improve Treatment HFA Premium Access Heart Failure 2018

ESC 365 is supported by

ESC 365 is supported by